Exhibit
10.1


 


[***] Certain
information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information
is not material and would likely cause competitive harm to the registrant if publicly disclosed.


 


SECURITIES
PURCHASE AGREEMENT


 


This Securities Purchase
Agreement (this “Agreement”) is dated as of July 2, 2020 (the “Effective Date”), between
LiveXLive Media, Inc., a Delaware corporation (the “Company”), and No Street Capital LLC, a Delaware limited
liability company (including its successors and assigns, the “Purchaser”).


 


WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to Purchaser,
and Purchaser, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.


 


NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the Company and Purchaser agree as follows:


 


Article
I.

DEFINITIONS


 


1.1 Definitions.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have
the meanings given to such terms in the Note (as defined herein), and (b) the following terms have the meanings set forth in this
Section 1.1:


 


“Account
Control Agreement(s)” means any agreement entered into by and among Purchaser, Company or any Subsidiary and a third
party bank or other institution (including a securities intermediary) in which Company or any Subsidiary maintains a deposit account
or an account holding investment property and which grants Purchaser a perfected security interest in the subject account or accounts.


 


“Action”
shall have the meaning assigned to such term in Section 3.1(j).


 


“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.


 


“Board
of Directors” means the board of directors of the Company.


 


“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.


 




    


     


    

 


“Capital
Stock” of any Person means any and all shares of, interests in, rights to purchase, warrants or options for, participations
in, or other equivalents of, in each case however designated, the equity of such Person, but excluding any debt securities convertible
into such equity.


 


“CFC”
means a Person that is a controlled foreign corporation under Section 957 of the Internal Revenue Code of 1986.


 


“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.


 


“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i) the Purchaser’s obligations to pay the Purchase Price, and (ii) the
Company’s obligations to deliver the Securities have been satisfied or waived.


 


“Closing
Material Change” shall mean any event, circumstance, change or effect occurring in whole or in part
after the Effective Date and prior to the Closing Date that the Purchaser reasonably determines in good faith, individually or
in the aggregate, is materially adverse or reasonably likely to be materially adverse to (a) the business, condition
(financial or otherwise), assets, liabilities, results or (short-term or long-term) prospects of the Company and the Subsidiaries,
taken as a whole, or (b) the ability of the Company to consummate the transactions contemplated by this Agreement.


 


“Collateral”
shall have the meaning assigned to such term in the Security Agreement.


 


“Commission”
means the Securities and Exchange Commission.


 


“Common
Stock” means the Common Stock of the Company, par value $0.001 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.


 


“Common
Stock Equivalents” shall have the meaning assigned to such term in the Note.


 


“Company
Counsel” shall have the meaning assigned to such term in the Note.


 


“Disclosure
Schedules” means the Disclosure Schedules delivered by the Company concurrently with the execution and delivery of this
Agreement.


 


“Disqualification
Event” shall have the meaning assigned to such term in Section 3.1(bb).


 


“Domestic
Subsidiary” means any Subsidiary that is incorporated or organized under the laws of any state of the United States or
the District of Columbia, other than any such Subsidiary owned directly or indirectly by a Foreign Subsidiary.


 




    2


     


    

 


“Equity
Interests” means, with respect to any Person, all of the shares of Capital Stock of (or other ownership or profit interests
in) such Person, all Common Stock Equivalents, all of the warrants, options or other rights for the purchase or acquisition from
such Person of shares of Capital Stock of (or other ownership or profit interests in) such Person, all of the securities convertible
into or exchangeable for shares of Capital Stock of (or other ownership or profit interests in) such Person or warrants, rights
or options for the purchase or acquisition from such Person of such shares (or such other interests), and all of the other ownership
or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting, and
whether or not such shares, warrants, options, rights or other interests are outstanding on any date of determination.


 


“Escrow
Agreement” means that certain Escrow Agreement among Purchaser, the Company and Keating Muething & Klekamp PLL dated
of even date herewith.


 


“Evaluation
Date” shall have the meaning assigned to such term in Section 3.1(dd).


 


“Exchange
Act” means the Securities Exchange Act of 1934, as amended.


 


“Foreign
Subsidiary” means any Subsidiary that is not a Domestic Subsidiary.


 


“FSHCO”
means any entity with no material assets or business activities other than ownership of equity interests in one or more Foreign
Subsidiaries that are CFCs.


 


“GAAP”
shall have the meaning assigned to such term in Section 3.1(h).


 


“Governmental
Authority” shall have the meaning assigned to such term in the Note.


 


“Indebtedness”
shall have the meaning assigned to such term in the Note.


 


“Intellectual
Property Rights” shall have the meaning assigned to such term in Section 3.1(n).


 


“Issuer
Covered Person” shall have the meaning assigned to such term in Section 3.1(bb).


 


“Lien”
shall have the meaning assigned to such term in the Note.


 


“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).


 


“Maximum
Rate” shall have the meaning assigned to such term in Section 5.16.


 


“Money
Laundering Laws” shall have the meaning assigned to such term in Section 3.1(aa).


 




    3


     


    

 


“Note”
means the 8.5% Subordinated Secured Convertible Note due as of the 2 year anniversary of the Closing Date, subject to the terms
therein, issued by the Company to the Purchaser hereunder, in the form of Exhibit A attached hereto.


 


“Note
Shares” shall have the meaning assigned to such term in the Note.


 


“OFAC”
shall have the meaning assigned to such term in Section 3.1(aa).


 


“Permits”
means all permits, licenses, registrations, certificates, orders, approvals, authorizations, consents, waivers, franchises, variances
and similar rights issued by or obtained from any Governmental Authority.


 


“Permitted
Lien” means the individual and collective reference to the following: (a) Liens for taxes, assessments and other governmental
charges or levies not yet due or Liens for taxes, assessments and other governmental charges or levies being contested in good
faith and by appropriate proceedings for which adequate reserves (in the good faith judgment of the management of the Company)
have been established in accordance with GAAP, (b) Liens imposed by law which were incurred in the ordinary course of the Company’s
business, such as carriers’, warehousemen’s, materialmen’s and mechanics’ Liens, statutory landlords’
Liens, and other similar Liens arising in the ordinary course of the Company’s business, and which (x) do not individually
or in the aggregate materially detract from the value of the property or assets subject to such Lien or materially impair the use
thereof in the operation of the business of the Company and its consolidated Subsidiaries or (y) are being contested in good faith
by appropriate proceedings, which proceedings have the effect of preventing for the foreseeable future the forfeiture or sale of
the property or asset subject to such Lien, (c) Liens in favor of the Holder and the Senior Lender, (d) Liens for reasonable and
customary banking fees granted to banks or other financial institutions in the ordinary course of business in connection with,
and which solely encumber, deposit, disbursement or concentration accounts (other than in connection with borrowed money) maintained
with such banks or financial institutions that do not exceed $50,000 in the aggregate, (e) Liens in connection with Indebtedness
incurred by lease obligations and purchase money indebtedness, incurred in connection with the acquisition of capital assets and
lease obligations with respect to newly acquired or leased assets, provided that such lease obligations and purchase money indebtedness
are only recourse to the assets being acquired or leased, (f) Liens consisting of deposits or pledges made in the ordinary course
of business in connection with workers’ compensation, unemployment, social security and similar laws, (g) Liens in favor
of any existing lenders in connection with any Subsidiary acquired after the Effective Date, provided that such Lien only encumbers
the assets of such after acquired Subsidiary and (h) Liens existing on the Effective Date which are disclosed on Schedule A.


 


“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.


 


“Principal
Market” shall have the meaning assigned to such term in the Note.


 




    4


     


    

 


“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.


 


“Public
Information Failure” shall have the meaning assigned to such term in Section 4.1(b).


 


“Public
Information Failure Payment” shall have the meaning assigned to such term in Section 4.1(b).


 


“Purchase
Price” means $15,000,000.


 


“Purchaser
Party” shall have the meaning assigned to such term in Section 4.9.


 


“Registration
Rights Agreement” shall mean that Registration Rights Agreement, dated as of the Closing Date, in form and substance
satisfactory to Purchaser in its sole discretion.


 


“Required
Approvals” shall have the meaning assigned to such term in Section 3.1(e).


 


“Required
Minimum” means 3,000,000 shares of Common Stock.


 


“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.


 


“SEC
Reports” shall have the meaning assigned to such term in Section 3.1(h).


 


“Securities”
means the Subscription Shares, the Note and the Note Shares.


 


“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


 


“Security
Agreement” means the Security Agreement, dated as of the Closing Date, among the Company, the Subsidiary Guarantors,
and the Purchaser in a form acceptable to Purchaser in its sole discretion.


 


“Security
Documents” means the Security Agreement, the Account Control Agreement(s), and any other documents and filing required
thereunder in order to grant the Purchaser a security interest in the assets of the Company as provided in the Security Agreement,
including all UCC-1 filing receipts.


 


“Senior
Lender” means JGB Capital LP and its affiliates party to that certain Securities Purchase Agreement dated June 29, 2018
with the Company, as amended, and their assigns.


 




    5


     


    

 


“Subordination
Agreement” means that Subordination Agreement, dated as of the Closing Date, among the Senior Lender (or such other party
satisfactory to Purchaser in its sole discretion), the Company and the Purchaser in form and substance satisfactory to Purchaser
in its sole discretion.


 


“Subscription
Shares” shall have the meaning assigned to such term in Section 2.1.


 


“Subsidiary”
shall have the meaning assigned to such term in the Note.


 


“Subsidiary
Guarantee” means a guarantee executed by each Subsidiary Guarantor in favor of Purchaser in a form satisfactory to Purchaser
in its sole discretion, as supplemented from time to time by execution and delivery of a guaranty joinder agreement or otherwise.


 


“Subsidiary
Guarantor” shall means each Subsidiary other than a Foreign Subsidiary that is a CFC or a FSHCO.


 


“Trading
Day” means a day on which the Principal Market is open for trading.


 


“Transaction
Documents” means this Agreement, the Note, the Security Agreement, the Subsidiary Guarantee, the Account Control Agreement(s),
the Subordination Agreement, the Registration Rights Agreement, and all exhibits and schedules thereto and hereto and any other
documents or agreements executed by the Company or any Subsidiary Guarantor in connection with the transactions contemplated hereunder.


 


“Transfer
Agent” means VStock Transfer, LLC, with a mailing address of 18 Lafayette Place, Woodmere, New York 11598, and any successor
transfer agent of the Company.


 


“Variable
Rate Transaction” means the issuance of any security that is convertible into, exercisable for, or that carries the right
to receive, Common Stock, and which security would constitute a ‘future priced security’ within the meaning of IM 5635-4
of the NASDAQ Listing Standards as in effect on the date hereof.


 


Article
II.

PURCHASE AND SALE


 


2.1 Closing.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchaser
agrees to purchase, (i) an aggregate of 500,000 shares of Common Stock (the “Subscription Shares”), and (ii)
the Note in the principal amount of $15,000,000. The Company and Purchaser shall deliver the other items set forth in Section
2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3,
the Closing shall occur at the offices of Keating Muething & Klekamp PLL, 1 E. 4th Street, Suite 1400, Cincinnati,
Ohio 45202 or such other location as the parties shall mutually agree.


 




    6


     


    

 


2.2 Deliveries.


 


(a) On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to Purchaser the following:


 


(i) this
Agreement duly executed by the Company;


 


(ii) evidence
of the Required Approvals (other than the filing of the Form D with the Commission which shall be obtained subsequent to the Closing
Date in accordance with Article IV);


 


(iii) a
legal opinion of Company Counsel, in form and substance reasonably acceptable to Purchaser;


 


(iv) an
ink-original Note registered in the name of Purchaser;


 


(v) the
Subsidiary Guarantee duly executed by each Subsidiary Guarantor;


 


(vi) the
Security Agreement duly executed by the Company along with all of the other Security Documents duly executed by the applicable
parties thereto;


 


(vii) the
Registration Rights Agreement duly executed by the Company;


 


(viii) each
other Transaction Document to which the Company is a party duly executed by the Company;


 


(ix) the
Company shall have issued irrevocable instructions to the Transfer Agent instructing the Transfer Agent to (x) deliver on an expedited
basis the Subscription Shares, registered in the name of the Purchaser, and (y) establish a share reserve for the issuance of Note
Shares equal to at least the Required Minimum; and


 


(x) except
as contemplated by Section 2.3(b)(xi)(y), the Subordination Agreement, duly executed by the Senior Lender (or such other party
satisfactory to Purchaser in its sole discretion) and the Company.


 


(b) On
or prior to the Closing Date, Purchaser shall deliver or cause to be delivered to the Company the following:


 


(i) this
Agreement duly executed by Purchaser;


 


(ii) subject
to the terms of the Escrow Agreement, the Purchase Price by wire transfer to the account specified in writing by the Company;


 


(iii) the
Security Agreement along with any other Security Documents to which Purchaser is a party duly executed by Purchaser;


 




    7


     


    

 


(iv) each
other Transaction Document to which Purchaser is a party duly executed by Purchaser;


 


(v) except
as contemplated by Section 2.3(b)(xi)(y), the Subordination Agreement duly executed by Purchaser; and


 


(vi) the
Registration Rights Agreement duly executed by Purchaser.


 


2.3 Closing
Conditions.


 


(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:


 


(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or a Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchaser contained herein (except to
the extent expressly made as of a specific date, in which case they shall be accurate as of such date);


 


(ii) all
obligations, covenants and agreements of Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and


 


(iii) the
delivery by Purchaser of the items set forth in Section 2.2(b).


 


(b) The
obligations of the Purchaser hereunder in connection with the Closing are subject to the following conditions being met:


 


(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Company contained herein (except to the
extent expressly made as of a specific date, in which case they shall be accurate as of such date);


 


(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;


 


(iii) the
delivery by the Company of the items set forth in Section 2.2(a);


 


(iv) no
Closing Material Change shall have occurred;


 


(v) the
Company shall have delivered a certificate, executed on behalf of the Company by its Secretary, dated as of the Closing Date, certifying
the resolutions adopted by the Board of Directors of the Company approving the transactions contemplated by this Agreement and
the other Transaction Documents, certifying the current versions of the Company’s certificate or articles of incorporation
and bylaws and certifying as to the signatures and authority of Persons signing the Transaction Documents and related documents
on behalf of the Company;


 




    8


     


    

 


(vi) the
Company shall have delivered a certificate, executed on behalf of the Company by its Chief Executive Officer or its Chief Financial
Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified in this Section 2.3(b);


 


(vii) a
security interest in substantially all of the assets of the Company and each Subsidiary Guarantor securing the Company’s
and each Subsidiary Guarantor’s obligations under the Transaction Documents shall have been created and perfected in favor
of the Purchaser; provided such security interest shall be limited in the case of any Foreign Subsidiary that is a CFC or FSHCO
to 65% of the voting stock of such entity;


 


(viii) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended or halted by the Principal Market
or the Commission and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by
such service, or on the Principal Market, nor shall a banking moratorium have been declared either by United States or New York
State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the
reasonable judgment of Purchaser, makes it impracticable or inadvisable to purchase the Note at the Closing;


 


(ix) the
transaction with [***] (“Target”) pursuant to that certain Agreement and Plan of Merger to be entered into by
the respective parties shall have closed in a manner and on a structure and terms and conditions reasonably satisfactory to Purchaser;
and


 


(x) either
the Company (x) obtains its Senior Lender’s consent to the transaction contemplated by the Transaction Documents, (y) repays
in full the outstanding obligations to its Senior Lender and the agreements with the Senior Lender are terminated, or (z) the Company
replaces its Senior Lender’s loan arrangement with another senior lender satisfactory to Purchaser in its sole discretion
which arrangement shall be on terms equal to or better than such arrangement and the agreements with the Senior Lender are terminated.


 


2.4 Conditions
Subsequent. The Company shall deliver any and all Account Control Agreements, duly executed by the Company or the applicable
Subsidiary Guarantor and the applicable depository bank, to the Purchaser as soon as possible after the Closing Date but in any
event within 10 Business Days following the Closing Date (or such later date as may be agreed by Purchaser in its sole discretion).


 




    9


     


    

 


Article
III.

REPRESENTATIONS AND WARRANTIES


 


3.1 Representations
and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed
a part hereof and shall qualify any representation or warranty otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules or to the extent the relevance of such disclosure to such representation
or warranty is reasonably apparent, the Company hereby makes the following representations and warranties as of the date hereof
and as of the Closing Date to the Purchaser as follows (except to the extent expressly made as of a specific date therein, in which
case they shall be accurate as of such date):


 


(a) Subsidiaries.
All of the direct and indirect Subsidiaries of the Company are set forth on Schedule 3.1(a). The Company owns, directly
or indirectly, all of the Equity Interests of each Subsidiary free and clear of any Liens (other than Permitted Liens), options
or warrants, and all of the issued and outstanding Equity Interests of each Subsidiary are validly issued and are fully paid, non-assessable
and free of preemptive and similar rights to subscribe for or purchase securities.


 


(b) Organization
and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company
nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, would not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity
or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, or
financial condition of the Company and the Subsidiaries, taken as a whole, (iii) a material adverse effect on the Company’s
ability to perform or pay in any material respect on a timely basis its obligations under any Transaction Document, or (iv) a material
adverse effect on the Collateral or the Purchaser’s Liens on the Collateral or the priority of such Liens (any of (i), (ii),
(iii), or (iv), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.


 




    10


     


    

 


(c) Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder,
subject to Required Approvals. The execution and delivery of this Agreement and each of the other Transaction Documents by the
Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s
stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each
other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and,
when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies, and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.


 


(d) No
Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien (other
than pursuant to the Transaction Documents) upon any of the properties or assets of the Company or any Subsidiary, or give to others
any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which
the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected,
or (iii) subject to the receipt of the Required Approvals, conflict with or result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court or Governmental Authority to which the Company or a Subsidiary
is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not have or reasonably be
expected to result in a Material Adverse Effect.


 


(e) Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other foreign, federal, state, local or other Governmental Authority
in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the notice
and/or application(s) to the Principal Market for the issuance of the Subscription Shares and Note Shares, (ii) the filing of UCC-1
financing statements with the appropriate filing office and intellectual property security interest filings with the USPTO and
US Copyright Office, (iii) the filing of Form D with the U.S. Securities and Exchange Commission, (iv) the filings contemplated
by Section 4.6 and (v) approval of the Transaction Documents by the Board of Directors (collectively, the “Required
Approvals”).


 




    11


     


    

 


(f) Issuance
of the Securities; Registration. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents or under applicable securities laws. The
Company has reserved from its duly authorized capital stock a number of shares of Common Stock sufficient for issuance of all of
the Note Shares up to the Required Minimum.


 


(g) Capitalization.
The capitalization of the Company is as set forth on Schedule 3.1(g). The Company has not issued any capital stock since
its most recently issued SEC Reports, other than as set forth on Schedule 3.1(g) pursuant to the exercise of employee stock
options under the Company’s stock incentive plans, the issuance of shares of Common Stock to employees or consultants pursuant
to the Company’s stock incentive plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding
as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as set forth on Schedule 3.1(g) or in the Transactions Documents, there are no outstanding options, warrants, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock,
or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue
additional shares of Common Stock or Common Stock Equivalents. Except as set forth on Schedule 3.1(g) or in the Transaction
Documents, the issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities
to any Person (other than the Purchaser) and will not result in a right of any holder of Company securities to adjust the exercise,
conversion, exchange or reset price under any of such securities. Except as set forth on Schedule 3.1(g), there are no outstanding
securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or
reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary, and there are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem
a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock”
plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized,
validly issued, fully paid and non-assessable, have been issued in compliance with all applicable foreign, federal and state securities
laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or
purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among
any of the Company’s stockholders.


 




    12


     


    

 


(h) SEC
Reports; Financial Statements. Since March 31, 2019, the Company has filed all reports, schedules, forms, statements and other
documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a)
or 15(d) thereof (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being
collectively referred to herein as the “SEC Reports”) on a timely basis or has qualified for a valid extension
of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective
dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The Company is not currently, and has not been in the prior 12 months, an issuer subject to paragraph
(i) of Rule 144. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.
Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied
on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP,
and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for
the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments.


 


(i) Material
Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest financial statements included within
the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i) there has been
no event, occurrence or development that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii)
neither the Company nor any Subsidiary has incurred any liabilities (contingent or otherwise) other than (A) trade payables and
accrued expenses incurred in the ordinary course of business consistent with past practice, and (B) liabilities not required to
be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii)
the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its
capital stock, and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company equity incentive plans. The Company does not have pending before the Commission any request for confidential
treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule
3.1(i), to the knowledge of the Company, no event, liability, fact, circumstance, occurrence or development has occurred or
exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses,
properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities
laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior
to the date that this representation is made.


 




    13


     


    

 


(j) Litigation.
Except as disclosed in Schedule 3.1(j), there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county,
local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity
or enforceability of any of the Transaction Documents or the Securities, or (ii) would, if there were an unfavorable decision,
have or reasonably be expected to result in a Material Adverse Effect. None of the Company, any Subsidiary, or any current director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state
securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending
or contemplated, any investigation by a Governmental Authority involving the Company or any current or former director or officer
of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.


 


(k) Compliance.
Neither the Company nor any Subsidiary, except in each case as would not have or reasonably be expected to result in a Material
Adverse Effect: (i) except as set forth on Schedule 3.1(k), is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary
under), nor has the Company or any Subsidiary, received, in the prior two (2) years, notice of a claim that it is in default under
or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party
or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation
of any applicable judgment, decree or order of any court, arbitrator or other Governmental Authority, or (iii) is or has been in
violation of any applicable statute, rule, ordinance or regulation of any Governmental Authority, including without limitation
all applicable foreign, federal, state and local laws relating to taxes, bribery and corruption, occupational health and safety,
product quality and safety and employment and labor matters and law related to the protection of the environment.


 


(l) Regulatory
Permits. The Company and the Subsidiaries possess all Permits necessary to conduct their respective businesses, except where
the failure to possess such Permits would not reasonably be expected to result in a Material Adverse Effect, and neither the Company
nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any such Permit.


 




    14


     


    

 


(m) Title
to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Permitted Liens; (ii) Liens as do not materially affect the value of such
property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries,
and (iii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance
with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under
lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company
and the Subsidiaries are in compliance, except as would not have or reasonably be expected to result in a Material Adverse Effect.
Each of LXL Influencers, KOKO (Camden) UK Limited and KOKO (Camden) Holdings (US), Inc. does not currently hold any assets and
will not hold any assets during the term of the Note.


 


(n) Intellectual
Property. To the knowledge of the Company, the Company and the Subsidiaries have, or have rights to use, all patents, patent
applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and
other intellectual property rights and similar rights as described in the SEC Reports as necessary or required for use in connection
with their respective businesses and which the failure to so have would reasonably be expected to have a Material Adverse Effect
(collectively, the “Intellectual Property Rights”). Except as disclosed on Schedule 3.1(n), none of,
and neither the Company nor any Subsidiary has received a written notice that any of the Intellectual Property Rights owned by
the Company or any of its Subsidiaries has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the
latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably
be expected to have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights that have
been registered with a Governmental Authority are enforceable and there is no existing infringement by another Person of any of
such registered Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect
the secrecy, confidentiality and value of all of their Intellectual Property Rights, except where failure to do so would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as disclosed on Schedule 3.1(n), the
Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual
Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual
Property Rights that are necessary to conduct its business.


 


(o) Insurance.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business without a significant increase in cost.


 




    15


     


    

 


(p) Certain
Fees. Except as set forth on Schedule 3.1(p), no brokerage or finder’s fees or commissions are or will be payable
by the Company or any Subsidiaries to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchaser shall have no obligation
with respect to any claims made by or on behalf of other Persons for fees payable by the Company or any Subsidiary of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.


 


(q) Registration
Rights. Except as described in the SEC Reports and as set forth on Schedule 3.1(q) and in the Registration Rights Agreement,
no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities
of the Company or any Subsidiary.


 


(r) Private
Placement. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchaser as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Principal Market.


 


(s) Investment
Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject
to registration under the Investment Company Act of 1940, as amended.


 


(t) Disclosure.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided the Purchaser or its agents or counsel with any
information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms
that the Purchaser will rely on the foregoing representation in effecting transactions in securities of the Company. All of the
disclosure furnished by or on behalf of the Company to the Purchaser regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, including the Disclosure Schedules, is true and correct in all material respects
and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in light of the circumstances under which they were made, not materially misleading. The press releases
disseminated by the Company since January 1, 2020, taken as a whole with the SEC Reports, do not contain any untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made and when made, not materially misleading. The Company acknowledges and
agrees that the Purchaser makes no or has not made any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in Section 3.2.


 




    16


     


    

 


(u) No
Integrated Offering. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would case this
offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval
provisions of any Principal Market on which any of the securities of the Company are listed or designated.


 


(v) Solvency;
Seniority. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable value of the Company’s
tangible assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and
other liabilities (including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably
small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into
account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements
and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would
receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient
to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to
incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). Except as set forth on Schedule 3.1(v), the Company has no knowledge of any facts or circumstances,
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any
jurisdiction within one year from the Closing Date. Schedule 3.1(v) sets forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. As of
the Closing Date and other than Indebtedness with the Senior Lender as of the Closing Date, (1) no Indebtedness or other claim
against the Company is senior to the Note in right of payment, whether with respect to interest or upon liquidation or dissolution,
or otherwise, and (2) no Indebtedness or other claim against any Subsidiary is senior to such Subsidiary’s obligations under
the Subsidiary Guarantee in right of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise.


 


(w) Tax
Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject,
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due
on such returns, reports and declarations, and (iii) has set aside on its books provision reasonably adequate for the payment of
all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid
taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or
of any Subsidiary know of no basis for any such claim. The Company is not and has never been a United States real property holding
corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify
upon Purchaser’s reasonable request at any time.


 




    17


     


    

 


(x) Acknowledgment
Regarding Purchaser’s Purchase of Securities. The Company acknowledges and agrees that the Purchaser is acting solely
in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or
in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchaser’s purchase of the Securities. The Company further represents to
Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely
on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.


 


(y) Acknowledgment
Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding,
it is understood and acknowledged by the Company that: (i) the Purchaser has not been asked by the Company to agree, nor has Purchaser
agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities
based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or
other transactions by Purchaser, specifically including, without limitation, short sales or “derivative” transactions,
before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company’s
publicly-traded securities, (iii) Purchaser, and counter-parties in “derivative” transactions to which Purchaser is
a party, directly or indirectly, may presently have a “short” position in the Common Stock, and (iv) Purchaser shall
not be deemed to have any affiliation with or control over any arm’s length counter-party in any “derivative”
transaction. The Company further understands and acknowledges that (y) Purchaser may engage in hedging activities at various times
during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the
Note Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce
the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities
are being conducted.  The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.


 


(z) Regulation
M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchase of,
any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting any other securities of the
Company.


 




    18


     


    

 


(aa)Office
of Foreign Assets Control; Money Laundering. Neither the Company nor any Subsidiary nor, to the Company’s knowledge,
any director, officer, agent, employee or affiliate of the Company or any Subsidiary, is currently subject to any United States
sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department (“OFAC”).The
operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial
record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1977, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”),
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving
the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary,
threatened.


 


(bb)No
Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer
of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under
the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”
and, together, “Issuer Covered Persons”) is subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except for a
Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any
Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure
obligations under Rule 506(e), and has furnished to the Purchaser a copy of any disclosures provided thereunder.


 


(cc)Other
Covered Persons. Except for the compensation payable as described on Schedule 3.1(p), the Company is not aware of any
Person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation
of purchasers in connection with the sale of any securities pursuant to Regulation D promulgated under the Securities Act.


 




    19


     


    

 


(dd)Sarbanes-Oxley;
Internal Accounting Controls. Except as set forth in the SEC Reports, the Company and the Subsidiaries are in compliance in
all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date
hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the
date hereof and as of the Closing Date. Except as set forth in the SEC Reports, the Company and the Subsidiaries maintain a system
of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in
accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and
the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to
be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated
the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered
by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company
presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the
effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, except as set forth in the SEC Reports, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the internal
control over financial reporting of the Company and its Subsidiaries.


 


(ee)Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the twelve (12) months preceding the date hereof, received notice from the Principal
Market to the effect that the Company is not in compliance with the listing or maintenance requirements of the Principal Market.
The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all
such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company and the Company is current in payment of the fees to the Depository Trust Company in connection with such electronic
transfer.


 


3.2 Representations
and Warranties of the Purchaser. Purchaser hereby represents and warrants as of the date hereof and as of the Closing Date
to the Company as follows (except to the extent expressly made as of a specific date therein, in which case they shall be accurate
as of such date):


 


(a) Organization;
Authority. Purchaser is an entity duly incorporated or formed, validly existing and in good standing under the laws of the
State of Delaware with full right, limited liability company power and authority to enter into and to consummate the transactions
contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and
delivery of the Transaction Documents and performance by Purchaser of the transactions contemplated by the Transaction Documents
have been duly authorized by all necessary limited liability company action on the part of Purchaser. Each Transaction Document
to which Purchaser is a party has been duly executed by Purchaser, and when delivered by Purchaser in accordance with the terms
hereof, will constitute the valid and legally binding obligation of Purchaser, enforceable against it in accordance with its terms,
except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other
laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies, and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.


 




    20


     


    

 


(b) Own
Account. Purchaser understands that the Securities are “restricted securities” and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any
applicable state securities law; provided, this representation and warranty shall not be deemed to limit Purchaser’s right
to sell the Securities in compliance with applicable federal and state securities laws or pursuant to the Registration Rights Agreement.


 


(c) Purchaser
Status. At the time Purchaser was offered the Securities, it was, and as of the date hereof it is, an “accredited investor”
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act.


 


(d) General
Solicitation. Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented
at any seminar or any other general solicitation or general advertisement.


 


The Company acknowledges
and agrees that the representations contained in Section 3.2 shall not modify, amend or affect Purchaser’s right to
rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained
in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transaction contemplated hereby. The Purchaser acknowledges and agrees that neither the Company nor
any Subsidiary makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
such representations and warranties.


 


Article
IV.

OTHER AGREEMENTS OF THE PARTIES


 


4.1 Furnishing
of Information; Public Information.


 


(a) Until
the time that Purchaser does not own Securities, the Company covenants to maintain the registration of the Common Stock under Section
12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace
period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company
is not then subject to the reporting requirements of the Exchange Act and to otherwise cause all public information requirements
of Rule 144(c), and, if applicable, all information requirements of Rule 144(i) to be satisfied.


 




    21


     


    

 


(b) At
any time during the period commencing from the 6 month anniversary of the date hereof and ending at such time that all of the Securities
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or
limitation pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current public information requirement
under Rule 144(c) (a “Public Information Failure”) (for the avoidance of doubt, a Public Information Failure
shall be deemed to have occurred during any extension pursuant to Rule 12b-25 of the deadline for the filing of the Company’s
annual and periodic reports with the Commission), then, in addition to Purchaser’s other available remedies, the Company
shall pay to Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction
of its ability to sell the Securities, an amount in cash, for each $1,000 of principal amount of Note (or Note Shares issued upon
conversion thereof) still held by Purchaser, equal to $2.50 on the day of a Public Information Failure and such amount on each
Trading Day thereafter until the earlier of (a) the date such Public Information Failure is cured, and (b) such time that such
public information is no longer required  for the Purchaser to transfer the Note Shares pursuant to Rule 144; provided, however,
that the Company shall, in no event, be required to pay an aggregate amount of liquidated damages under this Agreement and the
Note for each $1,000 of principal amount of Note (and any Note Shares issued in respect thereof) greater than $100.00.  The
payments to which Purchaser shall be entitled pursuant to this Section 4.3(b) are referred to herein as “Public
Information Failure Payments.”  Public Information Failure Payments shall be paid on the earlier of (i) the last
day of the calendar month during which such Public Information Failure Payments are incurred, and (ii) the third Business Day after
the event or failure giving rise to the Public Information Failure Payments is cured.  In the event the Company fails to make
Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate
of 0.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit Purchaser’s right to pursue
actual damages for the Public Information Failure, and Purchaser shall have the right to pursue all remedies available to it at
law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.


 


4.2 Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the
Securities for purposes of the rules and regulations of the Principal Market such that it would require stockholder approval prior
to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.


 


4.3 Acknowledgment
of Dilution. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares
of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations
under the Transaction Documents, including, without limitation, its obligation to issue the Note Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless
of the effect of any such dilution or any claim the Company may have against Purchaser and regardless of the dilutive effect that
such issuance may have on the ownership of the other stockholders of the Company.


 




    22


     


    

 


4.4 Rule
144(i). Section 6(b) of the Note is incorporated into this Section 4.4 by reference.


 


4.5 Conversion
Procedures. The forms of Notice of Conversion included in the Note, together with any broker or seller representation letter
required under the Note, collectively set forth the totality of the procedures required of the Purchaser in order to convert the
Note. Without limiting the preceding sentences, no ink-original Notice of Conversion shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any such notice be required in order to convert the Note. No additional
legal opinion, other information or instructions shall be required of the Purchaser to convert its Note. The Company shall honor
conversions of the Note and shall deliver Note Shares in accordance with the terms, conditions and time periods set forth in the
Transaction Documents.


 


4.6 Securities
Laws Disclosure; Publicity. The Company shall promptly after the execution of this Agreement (or in any case, by no later than
8:30 a.m. (local time in New York, New York) on or before the fourth Trading Day immediately following the date hereof, file with
the Commission a Current Report on Form 8-K disclosing all of the material terms hereof and such Transaction Documents as exhibits
thereto as the parties shall agree. The Company shall promptly after the Closing Date (or in any case, by no later than 8:30 a.m.
(local time in New York, New York) on or before the fourth Trading Day immediately following the Closing Date, file with the Commission
a Current Report on Form 8-K disclosing all of the material terms hereof and attaching the Transaction Documents as exhibits thereto
(the “Second Current Report”). Upon the filing of such Second Current Report, the Company represents to the Purchaser
that it shall have publicly disclosed all “material, non-public information” delivered to the Purchaser by the Company
or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. The Company and the Purchaser shall consult with each other in issuing any other public
announcements or press releases with respect to the transactions contemplated hereby, and neither the Company nor the Purchaser
shall issue any such public announcement or press release nor otherwise make any such public statement or communication without
the prior consent of the Company, with respect to any disclosure of the Purchaser, or without the prior consent of the Purchaser,
with respect to any disclosure of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, then the disclosing party shall, to the extent lawful and practicable (having regard to time and in the case
of the Company, the Company’s continuous disclosure obligations), promptly provide the other party with prior notice of such
public announcement, press release, public statement or communication.


 




    23


     


    

 


4.7 Disclosure
of Material Information; No Obligation of Confidentiality.


 


(a) Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company covenants
and agrees that neither it, nor any other Person acting on its behalf, has provided prior to the date hereof or will in the future
provide Purchaser or its agents or counsel with any information that the Company believes constitutes material non-public information
unless prior thereto Purchaser shall have entered into a written agreement with the Company regarding the confidentiality and use
of such information. The Company understands and confirms that Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. In the event of a breach of the foregoing covenant by the Company, or any of its Subsidiaries,
or any of its or their respective officers, directors, employees and agents, in addition to any other remedy provided herein or
in the Transaction Documents, the Company shall, unless otherwise agreed by Purchaser, publicly disclose any “material, non-public
information” in a Current Report on Form 8-K filed with the Commission within one (1) Business Day following the date that
it discloses such information to Purchaser or such earlier time as may be required by applicable law. Any Current Report on Form
8-K filed with the Commission by the Company pursuant to this Section 4.7(a) shall be subject to prior review and comment
by the Purchaser.  From and after the filing of any such Current Report on Form 8-K pursuant to this Section 4.7(a),
Purchaser shall not be deemed to be in possession of any material, nonpublic information regarding the Company existing as of the
time of such filing.


 


(b) Except
pursuant to any confidentiality agreement entered into by Purchaser as described in Section 4.7(a), Purchaser shall not
be deemed to have any obligation of confidentiality with respect to (i) any non-public information of the Company disclosed to
Purchaser in breach of Section 4.7(a) (whether or not the Company files a Current Report on Form 8-K as provided above),
(ii) the fact that Purchaser has exercised any of its rights and/or remedies under the Transaction Documents, or (iii) any information
obtained by Purchaser as a result of exercising any of its rights and/or remedies under the Transaction Documents. In addition,
Purchaser shall not be deemed to be in breach of any duty to the Company and/or to have misappropriated any non-public information
of the Company, if Purchaser engages in transactions of securities of the Company, including, without limitation, any hedging transactions,
short sales or any “derivative” transactions while in possession of such non-public information.


 


4.8 Use
of Proceeds. Except as set forth on Schedule 4.8, the Company shall use the net proceeds from the sale of the Note hereunder
to pay a part of the purchase price to acquire Target, for general corporate purposes and any debt repayment in the Company’s
ordinary course of business and shall not use such proceeds: (a) for the redemption of any Common Stock or Common Stock Equivalents,
or (b) in violation of the Foreign Corrupt Practices Act of 1970, as amended or similar laws or OFAC regulations. The parties agree
and acknowledge that the Company may use a portion of the proceeds of the Purchase Price, together with additional capital obtained
by the Company, to repay in full the outstanding obligations to its Senior Lender.


 




    24


     


    

 


4.9 Indemnification
of Purchaser. Subject to the provisions of this Section 4.9, the Company will indemnify and hold Purchaser and its directors,
officers, stockholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a
Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls Purchaser (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, stockholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title) of such controlling Persons (each, a “Purchaser Party”)
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees, costs of investigation and costs of enforcing this
indemnity that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents, or (b) any action
instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of
the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction
Documents (unless such action is based upon a breach of such Purchaser Party’s representations, warranties or covenants under
the Transaction Documents or any violations by such Purchaser Party of foreign, federal or state securities laws or any conduct
by such Purchaser Party which constitutes fraud, gross negligence, bad faith or willful misconduct). If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its
own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel
in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel, or (iii) in such action
there is, in the reasonable written opinion of counsel, a material conflict on any material issue between the position of the Company
and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable, actual and documented
fees and expenses of no more than one such separate counsel to all Purchaser Parties. The Company will not be liable to any Purchaser
Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior written consent,
which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or
liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents or is attributable to any conduct by such
Purchaser Party which constitutes fraud, gross negligence, bad faith or willful misconduct. The Company shall not settle or compromise
any claim for which a Purchaser Party seeks indemnification hereunder without the prior written consent of the Purchaser, which
consent shall not be unreasonably withheld or delayed. The indemnification required by this Section 4.9 shall be made by
periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are
incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.


 


4.10 Reservation
and Listing of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance
pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction
Documents, but at least equal to the Required Minimum. If, on any date, the number of authorized but unissued (and otherwise unreserved)
shares of Common Stock is insufficient to fulfill its obligations in full under the Transaction Documents on such date, then the
Board of Directors shall use commercially reasonable efforts to amend the Company’s certificate or articles of incorporation
to increase the number of authorized but unissued shares of Common Stock to at least the number required to fulfill its obligations
in full under the Transaction Documents at such time, as soon as possible and in any event not later than the seventy-fifth day
after such date.


 




    25


     


    

 


4.11 Variable
Rate Transactions. From the date hereof until such time as Purchaser does not hold the Note, without the consent of the Purchaser,
the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its
Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction.


 


4.12 Form
D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchaser at the Closing
under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such
actions promptly upon request of Purchaser.


 


4.13 No
Transfers to Competitors. Purchaser agrees that it shall not, directly or indirectly, sell, assign, transfer or otherwise dispose
of the Note to any Person identified on Schedule 4.13.


 


4.14 Shareholder
Rights Plan. No claim will be made or enforced by the Company or, with the consent of
the Company, any other Person, that Purchaser is an “Acquiring Person”
under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or
similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that Purchaser could be deemed to
trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under
any other agreement between the Company and Purchaser. 


 


Article
V.

MISCELLANEOUS


 


5.1 Fees
and Expenses. Simultaneously with execution of this Agreement, the Company shall pay Purchaser a $75,000 commitment fee (the
“Transaction Expense Amount”); provided that if the Closing occurs on or before July 30, 2020, Purchaser agrees
to reimburse the Company an amount equal to the difference between the Transaction Expense Amount and the amount of documented
legal fees and out-of-pocket expenses incurred by Purchaser in connection with the transaction contemplated by the Transaction
Agreements. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and
any conversion or exercise notice delivered by Purchaser), stamp taxes and other taxes and duties levied in connection with the
delivery of any Securities to the Purchaser.


 


5.2 Entire
Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or
written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.


 




    26


     


    

 


5.3 Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or email attachment as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Business Day, (b) the next Business Day after the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or email attachment as set forth on the signature pages attached hereto on a
day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, (c) the second Business Day following
the date of mailing, if sent by a nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom
such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto.


 


5.4 Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any
manner impair the exercise of any such right.


 


5.5 Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.


 


5.6 Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
Purchaser. Purchaser may assign, with written notice to the Company of such assignment, any or all of its rights under this Agreement
to any Person to whom Purchaser assigns or transfers any Securities in compliance with the Transaction Documents, provided that
such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the “Purchaser.”


 


5.7 No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.9 and this Section 5.7.


 




    27


     


    

 


5.8 Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the County of New Castle. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the State of Delaware for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper
or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any other manner permitted by law.


 


5.9 Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for a period no
longer than three (3) years from the Closing.


 


5.10 Execution.
This Agreement may be executed in two (2) or more counterparts, all of which when taken together shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it
being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile
transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.


 


5.11 Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.


 


5.12 Rescission
and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then Purchaser may rescind
or withdraw, in its discretion from time to time upon written notice to the Company, any relevant conversion, redemption or exercise
notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however,
that in the case of a rescission of a conversion or redemption of a Note, the Purchaser shall be required to return any shares
of Common Stock subject to any such rescinded conversion, redemption or exercise notice concurrently with the return to Purchaser
of the aggregate exercise price paid to the Company for such shares and the restoration of Purchaser’s right to acquire such
shares pursuant to Purchaser’s Note.


 




    28


     


    

 


5.13 Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction and receipt of a customary lost Security affidavit and indemnity.


 


5.14 Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
Purchaser and the Company will be entitled to seek specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents.


 


5.15 Payment
Set Aside. To the extent that the Company makes a payment or payments to Purchaser pursuant to any Transaction Document or
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any
law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to
the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued
in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.


 


5.16 Usury.
To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and
will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any
time hereafter in force, in connection with any claim, action or proceeding that may be brought by Purchaser in order to enforce
any right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction
Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments
in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”),
and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated
with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such
Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents
is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract
rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the effective date thereof
forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess of the
Maximum Rate is paid by the Company to Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess
shall be applied by Purchaser to the unpaid principal balance of any such indebtedness or be refunded to the Company, the manner
of handling such excess to be at Purchaser’s election.


 




    29


     


    

 


5.17 Liquidated
Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other
amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.


 


5.18 Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.


 


5.19 Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.


 


5.20 WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.


 


5.21 Termination. 
This Agreement may be terminated by (a) Purchaser, by written notice to the other parties, if the Closing has not been consummated
on or before July 30, 2020, or (b) the Company, by written notice to Purchaser, if the Closing has not been consummated on or before
July 30, 2020; provided, however, that in either case such termination will not affect the right of any party to
sue for any breach of this Agreement by any other party.


 


5.22 OID.
THE FOLLOWING INFORMATION IS SUPPLIED SOLELY FOR U.S. FEDERAL INCOME TAX PURPOSES. THE NOTE WAS ISSUED WITH “ORIGINAL
ISSUE DISCOUNT” (“OID”) WITHIN THE MEANING OF SECTION 1273 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE
“CODE”), AND THIS LEGEND IS REQUIRED BY SECTION 1275(c) OF THE CODE. PURCHASER MAY OBTAIN INFORMATION REGARDING THE
AMOUNT OF ANY OID, THE ISSUE PRICE, THE ISSUE DATE, AND THE YIELD TO MATURITY RELATING TO THE NOTE BY CONTACTING THE ISSUER AT
LIVEXLIVE MEDIA, INC., 9200 SUNSET BOULEVARD, SUITE 1201, WEST HOLLYWOOD, CA 90069.


 


(Signature Pages Follow)


 




    30


     


    

 


IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.


 


	LiveXLive Media, Inc.	 	Address for Notice:
	 	 	 
	 	 	9200 Sunset Boulevard 
	 	 	Suite #1201
	 	 	West Hollywood, CA 90069
	 	 	Fax:
	By:	/s/ Robert S. Ellin	 	E-mail: rob@livexlive.com and 
	Name:	Robert S. Ellin	 	tenia@livexlive.com
	Title:	CEO	 	 
	 	 	 
	With a copy to (which shall not constitute notice):	 	 
	 	 	 
	Foley Shechter Ablovatskiy LLP	 	 
	
        1359 Broadway, 20th Floor, Suite 2001

        New York, NY 10018
	 	 
	Attn: Sasha Ablovatskiy, Esq.	 	 
	Email: sablovatskiy@foleyshechter.com 	 	 


 


[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]


 




    31


     


    

 


 


[PURCHASER SIGNATURE PAGE TO LIVEXLIVE MEDIA,
INC. SECURITIES PURCHASE AGREEMENT]


 


IN WITNESS WHEREOF,
the undersigned has caused this Securities Purchase Agreement to be duly executed by its respective authorized signatories as of
the date first indicated above.


 


	Name of Purchaser:	No Street Capital LLC
	Signature of Authorized Signatory of Purchaser:   	/s/ Jeff Osher
	Name of Authorized Signatory:	Jeff Osher
	Title of Authorized Signatory:	Managing Member
	Email Address of Authorized Signatory:	 
	Facsimile Number of Authorized Signatory:	 
	Address for Notice to Purchaser:	 


 


c/o No Street Capital LLC


505 Montgomery, Suite 1250

San Francisco, CA 94111


 


With a copy to (which shall not constitute
notice):


 


Keating Muething & Klekamp PLL

1 East Fourth Street, Suite 1400

Cincinnati, Ohio 45202

Attention: Michael J. Moeddel


 


Address for Delivery of Securities to Purchaser
(if not same as address for notice):


 


c/o No Street Capital LLC


505 Montgomery, Suite 1250

San Francisco, CA 94111


 


Purchase Price: $15,000,000


 


 


32